MayM, HrudkaJ, ElstL, RegauerS. Letter to the editor: advancing prognostic stratification in PSCC: developing predictive models as the next pivotal step. J Natl Compr Canc Netw2025;23:e257038.
MayM, HrudkaJ, ElstL, RegauerS. Letter to the editor: advancing prognostic stratification in PSCC: developing predictive models as the next pivotal step. J Natl Compr Canc Netw 2025;23:e257038.)| false
MustasamA, ParzaK, IonescuF, et al.The prognostic role of HPV or p16INK4a status in penile squamous cell carcinoma: a meta-analysis. J Natl Compr Canc Netw2025;23:e247078.
MustasamA, ParzaK, IonescuF, The prognostic role of HPV or p16INK4a status in penile squamous cell carcinoma: a meta-analysis. J Natl Compr Canc Netw 2025;23:e247078.)| false
ChahoudJ, ZachariasNM, PhamR, et al.Prognostic significance of p16 and Its relationship with human papillomavirus status in patients with penile squamous cell carcinoma: results of 5 years follow-up. Cancers (Basel)2022;14:6024.
ChahoudJ, ZachariasNM, PhamR, Prognostic significance of p16 and Its relationship with human papillomavirus status in patients with penile squamous cell carcinoma: results of 5 years follow-up. Cancers (Basel) 2022;14:6024.)| false
ElstL, PhilipsG, VandermaesenK, et al.Single-cell atlas of penile cancer reveals TP53 mutations as a driver of an aggressive phenotype, irrespective of human papillomavirus status, and provides clues for treatment personalization. Eur Urol2024;86:114–127.
ElstL, PhilipsG, VandermaesenK, Single-cell atlas of penile cancer reveals TP53 mutations as a driver of an aggressive phenotype, irrespective of human papillomavirus status, and provides clues for treatment personalization. Eur Urol 2024;86:114–127.)| false
ChahoudJ, YuX, NecchiA, SpiessPE. TP53 mutations emerge as a critical biomarker in penile cancer, superseding human papillomavirus status. Eur Urol2024;86:128–129.
CigliolaA, PrakashG, LiR, et al.Current status and challenges in rare genitourinary cancer research and future directions. Curr Oncol Rep2024;26:977–990.
CigliolaA, PrakashG, LiR, Current status and challenges in rare genitourinary cancer research and future directions. Curr Oncol Rep 2024;26:977–990.)| false